Zoetis Inc (ZTS)
176.71
+1.04
(+0.59%)
USD |
NYSE |
Nov 21, 16:00
176.71
0.00 (0.00%)
Pre-Market: 20:00
Zoetis Shareholders Equity (Quarterly): 5.234B for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 5.234B |
June 30, 2024 | 4.966B |
March 31, 2024 | 5.058B |
December 31, 2023 | 4.997B |
September 30, 2023 | 5.078B |
June 30, 2023 | 4.625B |
March 31, 2023 | 4.494B |
December 31, 2022 | 4.405B |
September 30, 2022 | 4.663B |
June 30, 2022 | 4.58B |
March 31, 2022 | 4.658B |
December 31, 2021 | 4.543B |
September 30, 2021 | 4.679B |
June 30, 2021 | 4.35B |
March 31, 2021 | 4.089B |
December 31, 2020 | 3.769B |
September 30, 2020 | 3.602B |
June 30, 2020 | 2.982B |
March 31, 2020 | 2.753B |
December 31, 2019 | 2.708B |
September 30, 2019 | 2.678B |
June 30, 2019 | 2.411B |
March 31, 2019 | 2.317B |
December 31, 2018 | 2.185B |
September 30, 2018 | 2.118B |
Date | Value |
---|---|
June 30, 2018 | 1.97B |
March 31, 2018 | 1.96B |
December 31, 2017 | 1.77B |
September 30, 2017 | 1.989B |
June 30, 2017 | 1.715B |
March 31, 2017 | 1.609B |
December 31, 2016 | 1.487B |
September 30, 2016 | 1.585B |
June 30, 2016 | 1.357B |
March 31, 2016 | 1.165B |
December 31, 2015 | 1.068B |
September 30, 2015 | 1.229B |
June 30, 2015 | 1.176B |
March 31, 2015 | 1.278B |
December 31, 2014 | 1.311B |
September 30, 2014 | 1.364B |
June 30, 2014 | 1.26B |
March 31, 2014 | 1.077B |
December 31, 2013 | 940.00M |
September 30, 2013 | 843.00M |
June 30, 2013 | 800.00M |
March 31, 2013 | 709.00M |
December 31, 2012 | 4.026B |
September 30, 2012 | 4.094B |
June 30, 2012 | 3.915B |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
2.708B
Minimum
Dec 2019
5.234B
Maximum
Sep 2024
4.312B
Average
4.562B
Median
Shareholders Equity (Quarterly) Benchmarks
Pfizer Inc | 92.29B |
Regeneron Pharmaceuticals Inc | 29.33B |
Vertex Pharmaceuticals Inc | 15.63B |
Alnylam Pharmaceuticals Inc | 32.35M |
Biomarin Pharmaceutical Inc | 5.413B |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 14.36B |
Total Liabilities (Quarterly) | 9.123B |
Debt to Equity Ratio | 1.256 |
Current Ratio | 3.691 |
Net Debt Paydown Yield | -0.00% |